Table 2.

Incidence and rate of hypoglycaemia

	CSII N = 209	MDI N = 211	Ratio CSII/MDI	95% CI	P‐value
Documented symptomatic ≤70 mg/dL
Incidence, n (%)	183 (87.6)	193 (91.9)	0.61	(0.32, 1.16)	0.13
1‐year event rate	37.0 ± 3.69	33.9 ± 3.01	1.09	(0.88, 1.35)	0.42
Documented symptomatic <54 mg/dL
Incidence, n (%)	152 (72.7)	155 (73.8)	0.95	(0.61, 1.47)	0.81
1‐year event rate	14.4 ± 1.76	13.8 ± 1.43	1.04	(0.80, 1.35)	0.76
Nocturnal ≤70 mg/dL
Incidence, n (%)	169 (80.9)	167 (79.5)	1.09	(0.67, 1.79)	0.72
1‐year event rate	19.6 ± 2.25	11.8 ± 1.13	1.66	(1.29, 2.13)	<0.001
Nocturnal <54 mg/dL
Incidence, n (%)	123 (58.9)	126 (60.0)	0.95	(0.64, 1.41)	0.80
1‐year event rate	8.18 ± 1.10	5.39 ± 0.66	1.52	(1.11, 2.07)	0.008
Severe hypoglycaemia
Incidence, n (%)	11 (5.26)	5 (2.38)	2.28	(0.78, 6.72)	0.13
1‐year event rate	0.11 ± 0.04	0.05 ± 0.03	2.45	(0.85, 7.06)	0.096

Abbreviations: CSII, continuous subcutaneous insulin infusion; MDI, multiple daily injection.

Data are LS mean ± SE or n (%).